Latest News for: gri

Edit

GRI Bio Announces Reverse Stock Split (Gri Bio Inc)

Public Technologies 21 Jan 2026
). The text version of this document is not available ... Gri Bio Inc.
Edit

GRI Bio Announces Reverse Stock Split

Nasdaq Globe Newswire 21 Jan 2026
GRI’s common stock is expected to begin trading on a post-split adjusted basis on January 26, 2026 ... .
Edit

GRI Bio Announces Reverse Stock Split (Form 8-K) (Gri Bio Inc)

Public Technologies 21 Jan 2026
GRI) ("GRI Bio" or the "Company"), a biotechnology company advancing an innovative pipeline of immune cell modulators for the treatment of inflammatory, fibrotic and autoimmune ...
Edit

Failure to Satisfy Listing Rule (Form 8-K) (Gri Bio Inc)

Public Technologies 16 Jan 2026
) Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 15, 2026, GRI Bio, Inc ... Attachments Original document Permalink. Disclaimer. Gri Bio Inc ... (noodl. 128936671) .
Edit

Proxy Results (Form 8-K) (Gri Bio Inc)

Public Technologies 15 Jan 2026
) Item 5.07 Submission of Matters to a Vote of Security Holders. On January 15, 2026 at 9.00 a.m. Eastern Time, GRI Bio, Inc ... The following actions were taken at the Special Meeting.. Proposal 1 ... 4,218,643 652,223 3,859 -. Proposal 2 ... Gri Bio Inc ... (noodl.
Edit

GRI Bio, Inc. 2223 Avenida de la Playa, #208 La Jolla, California 92037 (Form 8-K) (Gri Bio Inc)

Public Technologies 09 Jan 2026
) GRI Bio, Inc. 2223 Avenida de la Playa, #208 ... We have acted as counsel to GRI Bio, Inc., a Delaware corporation (the "Company"), with respect to certain matters in connection with the Registration Statement on Form S-3 (File No ... Gri Bio Inc.
Edit

Supplemental Prospectus (Form 424B5) (Gri Bio Inc)

Public Technologies 09 Jan 2026
). Filed pursuant to Rule 424(b)(5). Registration No. 333-279348. PROSPECTUS SUPPLEMENT ... GRI BIO, INC. Up to $7,379,813. Common Stock ... Our Common Stock is listed on the Nasdaq Capital Market under the symbol "GRI" ... H.C ... Disclaimer. Gri Bio Inc ... (noodl.
Edit

GRI Bio Announces Additional Positive Data from Phase 2a Study in Idiopathic Pulmonary Fibrosis, Strengthening Clinical Proof-of-Concept for GRI-0621 (Form 8-K) (Gri Bio Inc)

Public Technologies 08 Jan 2026
GRI) ("GRI Bio" or the "Company"), a biotechnology company advancing an innovative pipeline of immune cell modulators for the treatment of inflammatory, fibrotic and autoimmune ...
Edit

GRI Bio Announces Additional Positive Data from Phase 2a Study in Idiopathic Pulmonary Fibrosis, Strengthening ...

Nasdaq Globe Newswire 08 Jan 2026
New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung repair, and improved lung function ... .
Edit

Joseph B. Gries,II

The Citizens' Voice 08 Jan 2026
Joseph B. Gries, II, 63, of Dallas, passed away unexpectedly Sunday, January 4, 2026, at his home. Born in Wilkes-Barre, he was the son of the late Joseph B. and Ann Marie Gries ... Bank and Deutsche Bank ... Robert D. Elias ... Main St., Shavertown ... Rev ... Gries II.
Edit

Proxy Statement (Form DEF 14A) (Gri Bio Inc)

Public Technologies 29 Dec 2025
GRI BIO, INC ... You are cordially invited to attend a special meeting of stockholders (the "Special Meeting") of GRI Bio, Inc., a Delaware corporation (the "Company"), to be held on January 15, 2026, beginning at 9.00 a.m.
Edit

Updated "GRI Standards Content Index" page with data from Integrated Report 2025 (Nippon Paint Holdings Co Ltd)

Public Technologies 26 Dec 2025
Nippon Paint Holdings "Integrated Report 2025" refers to GRI Standards (Universal Standards <1, 2 and, 3> and topic-specific Standards <200, 300, and 400>) ... GRI 1. Foundation GRI 2. General Disclosures 2021 GRI 3 ... GRI 1 used GRI 1.
×